News & Updates

Atezolizumab-bevacizumab combo continues to win in advanced HCC

12 May 2021 by

The combination of the immune checkpoint inhibitor atezolizumab and the angiogenesis inhibitor bevacizumab continues to demonstrate significant clinical benefits vs the oral multikinase inhibitor sorafenib in patients with unresectable hepatocellular carcinoma (HCC), according to updated results from the IMbrave150 trial.

Atezolizumab-bevacizumab combo continues to win in advanced HCC

12 May 2021

Higher postinduction infliximab concentrations tied to improved outcomes in fistulizing CD

12 May 2021

Higher concentrations of infliximab postinduction appear to result in early and long-term favourable therapeutic outcomes in patients with fistulizing Crohn’s disease (CD), a study has found.

Higher postinduction infliximab concentrations tied to improved outcomes in fistulizing CD

12 May 2021

Sintilimab shows potential as second-line treatment option for squamous NSCLC

12 May 2021 by

The anti-PD-1 monoclonal antibody sintilimab outperformed docetaxel as second-line treatment for advanced and metastatic squamous non-small-cell lung cancer (NSCLC), according to the results of the phase III ORIENT-3 trial presented at AACR 2021.

Sintilimab shows potential as second-line treatment option for squamous NSCLC

12 May 2021

AI still not ready for clinical use against COVID-19

12 May 2021 by

Despite its big potential in boosting healthcare quality, artificial intelligence (AI) still seems immature to be clinically deployed against the novel coronavirus disease (COVID-19) pandemic, according to a recent Singapore systematic review.

AI still not ready for clinical use against COVID-19

12 May 2021

Real-world study affirms benefit of mepolizumab in severe eosinophilic asthma

12 May 2021

Interleukin 5 (IL-5) inhibition with mepolizumab appears to improve asthma control, cutting the incidences of exacerbations and hospitalizations, in patients with severe eosinophilic asthma treated in a real-world setting, a study reports.

Real-world study affirms benefit of mepolizumab in severe eosinophilic asthma

12 May 2021

Dual-release hydrocortisone boosts cognition, sleep

12 May 2021

Use of dual-release hydrocortisone in the treatment of patients with adrenal insufficiency appears to confer extended benefits, such as that for cognitive function and quality of sleep, a study has found.

Dual-release hydrocortisone boosts cognition, sleep

12 May 2021

Neuro features common in children with SARS-CoV-2–related inflammatory syndrome

11 May 2021 by

About 50 percent of children who develop Paediatric Inflammatory Multisystem Syndrome Temporally associated with SARS-CoV-2 (PIMS-TS) present with neurological features, according to a small study presented at AAN 2021.

Neuro features common in children with SARS-CoV-2–related inflammatory syndrome

11 May 2021

Gait analysis differentiates progressive supranuclear palsy from Parkinson’s

11 May 2021

Gait patterns may help distinguish progressive supranuclear palsy from Parkinson’s disease patients, with the former showing compromised velocity and dynamic stability, a recent study has found.

Gait analysis differentiates progressive supranuclear palsy from Parkinson’s

11 May 2021

Hypertension after COVID-19 vaccine? Swiss study

11 May 2021 by

A very small proportion of people developed stage III hypertension within minutes after getting an mRNA-based COVID-19 vaccine, reports a case series study from Switzerland.

Hypertension after COVID-19 vaccine? Swiss study

11 May 2021

Etanercept does better than methotrexate at keeping RA in remission

11 May 2021 by

Rheumatoid arthritis (RA) patients achieving remission with the combination of methotrexate plus etanercept may be able to maintain their status by stopping the former and continuing treatment with the latter, as shown in the SEAM-RA* trial. In the maintenance setting, etanercept monotherapy does a better job than methotrexate alone and as good as the combination of the two drugs.

Etanercept does better than methotrexate at keeping RA in remission

11 May 2021

News & Updates

Filter by Specialty:

Specialty:

Atezolizumab-bevacizumab combo continues to win in advanced HCC

Atezolizumab-bevacizumab combo continues to win in advanced HCC

Higher postinduction infliximab concentrations tied to improved outcomes in fistulizing CD

Higher postinduction infliximab concentrations tied to improved outcomes in fistulizing CD

Sintilimab shows potential as second-line treatment option for squamous NSCLC

Sintilimab shows potential as second-line treatment option for squamous NSCLC

AI still not ready for clinical use against COVID-19

AI still not ready for clinical use against COVID-19

Real-world study affirms benefit of mepolizumab in severe eosinophilic asthma

Real-world study affirms benefit of mepolizumab in severe eosinophilic asthma

Dual-release hydrocortisone boosts cognition, sleep

Dual-release hydrocortisone boosts cognition, sleep

Neuro features common in children with SARS-CoV-2–related inflammatory syndrome

Neuro features common in children with SARS-CoV-2–related inflammatory syndrome

Gait analysis differentiates progressive supranuclear palsy from Parkinson’s

Gait analysis differentiates progressive supranuclear palsy from Parkinson’s

Hypertension after COVID-19 vaccine? Swiss study

Hypertension after COVID-19 vaccine? Swiss study

Etanercept does better than methotrexate at keeping RA in remission

Etanercept does better than methotrexate at keeping RA in remission